AzTrials
AzTrials

A Patient Discharged From an Acute-care Hospital Who Had an Acute IllnessNCT03178513

Post-Acute Physician Home Visit Program

A study testing Home visit in people with A Patient Discharged From an Acute-care Hospital Who Had an Acute Illness, run by Brigham and Women's Hospital at 2 sites in United States.

Completed

Finished. The study has ended and is not enrolling. Results may be posted on the official record.

Official record
Search all trials

Trial summary

New or worsening symptoms following discharge from the hospital likely leads to unplanned readmission. These rates are higher than desired and costly to patients, payers, and providers. Read more about this study

Who is it for?
Ages 18 years and older
What is being tested?
Home visit
Could I receive a placebo?
No, everyone receives an active treatment
How many people
51 participants
Where
2 sitesUnited States
Study dates
6 Jun 2017to 20 Jan 2018
Phase
Interventional
Are there results?
None posted in the registry

Key requirements

Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.

  • Ages 18 years and older
  • All sexes
  • No healthy volunteers
  • Adult, Older adult

Who may be able to join

  • Resides within either a 5-mile or 20-minute driving radius of Brigham and Women's Hospital (BWH) or Brigham and Women's Faulkner Hospital (BWFH) emergency room
  • Has capacity to consent to study
  • >=18 years old

Who cannot join

  • Undomiciled
  • In police custody
  • Domestic violence screen positive

Trial locations and contacts

2 sites in 1 country.

United States2 sites
  • Brigham and Women's Hospital

    Boston, Massachusetts, 02115

  • Brigham and Women's Faulkner Hospital

    Boston, Massachusetts, 02130

Other trials in United States

About this study

Official title: Post-Acute Physician Home Visits: A Randomized Controlled Trial

New or worsening symptoms following discharge from the hospital likely leads to unplanned readmission. These rates are higher than desired and costly to patients, payers, and providers. Many interventions have unsuccessfully attempted to reduce readmissions, but few have provided in-home personnel to patients transitioning from acute care back to ambulatory care. Still fewer have involved a physician in the home. We therefore will test the effect of a physician home visit to a patient's home who was discharged in the last 4 days.

Being tested
Home visit

What participants receive

What participants receive. In a randomised study each person is assigned to one group by chance.

  • Home visitOther

    The visit will be entirely patient tailored, last approximately one hour, and at a minimum will entail:

    • Medical assessment
    • Psychosocial assessment
    • Medication reconciliation
    • Follow-up of inpatient primary team's specific recommendations
    • Follow-up, as needed, with primary care team or inpatient team
Study groups in NCT03178513
Study groupRoleWhat they receive
Home visitExperimentalA participant in this arm will receive a home visit after discharge from the hospital.
Receives: Other: Home visit
Usual CareNo interventionA participant in this arm will not receive a home visit after discharge from the hospital.

What is being measured

The primary outcome is the main question the study is designed to answer.

  1. New or worsening symptoms

    "Since you got home from the hospital, have you had any symptoms at all?" If no, stop. If yes, continue.

    "I'm going to read off a list of symptoms, and I want you to tell me if that symptom is new or has gotten worse since you left the hospital. Please don't include symptoms that have stayed the same since you were in the hospital." For each affirmative, double check if the symptom is new or has gotten worse since getting out of the hospital. Only if new or worse, mark yes.

    Measured: 30 days after discharge from hospital

Secondary outcomes (9)
  1. Total cost, 30-days post discharge

    Measured: Day of discharge to 30 days later

  2. Total reimbursement, 30-days post discharge

    Measured: Day of discharge to 30 days later

  3. 3-item Care Transition Measure, score

    Measured: 30 days after discharge

  4. Primary care provider follow-up within 14 days, y/n

    Measured: Day of discharge to 14 days later

  5. Ability to carry out the discharge plan, score

    I would like to ask you about some more problems that you might have faced after you left the hospital one month ago. I will read some statements and ask if you agree or disagree.

    Measured: 30 days after discharge

  6. Change in medication list due to home visit, y/n

    Physician-initiated medication change during home visit

    Measured: Day of home visit

  7. Receipt of prescribed medicines following discharge, y/n

    Pharmacy confirmation

    Measured: 30 days after discharge

  8. Unplanned 30-day readmission(s) after index hospitalization, y/n

    Measured: 30 days after discharge

  9. Unplanned 30-day readmission(s) after index hospitalization, #

    Measured: 30 days after discharge

Timeline

From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.

  1. First posted7 Jun 2017
  2. Study start6 Jun 2017
  3. Primary completion20 Jan 2018
  4. Study completion20 Jan 2018

Resources

More details

For doctors and researchers: how the study is designed, who runs it, and its registry IDs.

Study design
Study type
Interventional
Phase
Phase N/A
Primary purpose
Supportive care
Allocation
Randomised
Intervention model
Parallel groups
Masking
None (open label)
Enrolment
51 participants (actual)
IDs, dates and publications
ClinicalTrials.gov ID
NCT03178513
Sponsor's protocol ID
P000719
Status last verified
Aug 2019
First submitted
5 Jun 2017
Last updated
13 Aug 2019
Results posted
No
Data monitoring committee
No
FDA-regulated drug
No
FDA-regulated device
No
Individual data sharing
No

Publications

  • Epstein K, Juarez E, Loya K, Gorman MJ, Singer A. Frequency of new or worsening symptoms in the posthospitalization period. J Hosp Med. 2007 Mar;2(2):58-68. doi: 10.1002/jhm.170.

    PubMed 17431881
  • Boling PA. Care transitions and home health care. Clin Geriatr Med. 2009 Feb;25(1):135-48, viii. doi: 10.1016/j.cger.2008.11.005.

    PubMed 19217498
  • Meyer GS, Gibbons RV. House calls to the elderly--a vanishing practice among physicians. N Engl J Med. 1997 Dec 18;337(25):1815-20. doi: 10.1056/NEJM199712183372507.

    PubMed 9400040
  • Wong FK, Chow SK, Chan TM, Tam SK. Comparison of effects between home visits with telephone calls and telephone calls only for transitional discharge support: a randomised controlled trial. Age Ageing. 2014 Jan;43(1):91-7. doi: 10.1093/ageing/aft123. Epub 2013 Aug 26.

    PubMed 23978408
  • Branowicki PM, Vessey JA, Graham DA, McCabe MA, Clapp AL, Blaine K, O'Neill MR, Gouthro JA, Snydeman CK, Kline NE, Chiang VW, Cannon C, Berry JG. Meta-Analysis of Clinical Trials That Evaluate the Effectiveness of Hospital-Initiated Postdischarge Interventions on Hospital Readmission. J Healthc Qual. 2017 Nov/Dec;39(6):354-366. doi: 10.1097/JHQ.0000000000000057.

    PubMed 27631713
  • Wolff JL, Meadow A, Boyd CM, Weiss CO, Leff B. Physician evaluation and management of Medicare home health patients. Med Care. 2009 Nov;47(11):1147-55. doi: 10.1097/MLR.0b013e3181b58e30.

    PubMed 19786916

Questions about this trial

What is this clinical trial studying?

A study testing Home visit in people with A Patient Discharged From an Acute-care Hospital Who Had an Acute Illness, run by Brigham and Women's Hospital at 2 sites in United States.

The full registered description is in the About this study section and the official record.

Who may be eligible to take part?

The sponsor lists 3 inclusion and 3 exclusion criteria. Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.

Is this clinical trial currently recruiting?

The record says: finished, as of the sponsor's last update on 13 Aug 2019. Status can change between updates, so confirm with the study contact before making plans.

Where is the study taking place?

The record lists 2 sites in United States. Whether a site is taking part right now should be confirmed with that site. See every site.

What are the possible benefits and risks?

They depend on the study and the treatment, and no study can promise a benefit. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.

Are results available for this study?

The study is completed, but results are not available in the source record. That does not mean the treatment did or did not work.

How can a doctor refer a patient or contact the research team?

The record lists no contact. The official record names the sponsor, who can be asked directly. AzTrials does not enrol participants or take referrals.

What does the primary outcome measure?

New or worsening symptoms (time frame: 30 days after discharge from hospital). It is what the study was designed to measure, not a finding.

Where can I read the original study information?

On the ClinicalTrials.gov record for NCT03178513, which also lists 6 linked publications.

Does a listing mean the treatment is approved or proven to work?

No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.

How often is this information updated?

AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 13 Aug 2019.

Free account

Keep searching with a free account

You’ve used your 3 free searches for this session. Log in or create a free AzTrials account to keep searching clinical trials and save the ones you want to follow.

Create a free accountLog in